Feature Story

Impact of US funding cuts on HIV programmes in Lesotho

14 April 2025

Immediate risks or disruptions

  1. Vertical transmission services: An impact assessment conducted by the Ministry of Health, supported by UNICEF, confirms:
    • Staffing gaps and shortages: There are significant staffing gaps affecting the availability of counsellors and other essential personnel.
    • Testing disruptions: HIV testing services are disrupted, with specific issues such as a non-operational point-of-care machine in one district.
    • Overcrowding: There is overcrowding in health facilities across all 10 districts due to staff shortages.
    • Data quality issues: Data completion and quality are severely impacted as nurses struggle with using the registers.
    • Resource allocation: The field assessment highlights the need for reprogramming of, and additional, resources.
  2. Service restart challenges:
    • Partners who received waivers to restart services are facing difficulties in resuming operations effectively.

Politically relevant updates

  1. Government actions:
    • A national resource mapping exercise has been launched by the Ministry of Health to guide reprogramming within the health sector. This exercise aims to provide a detailed understanding of available resources to support broader health sector interventions.

Feature Story

Impact of US Funding Cuts on HIV Programmes in Côte d'Ivoire

09 April 2025

Immediate Risks and Disruptions

  • The US waiver allowing the continuation of lifesaving treatment and the court order allowing CDC-led activities to resume resulted in the resumption of the provision of antiretroviral treatment (ART) and prevention of vertical transmission of HIV.
    • Activities for key populations, HIV-prevention, human rights, and community-led monitoring (CLM) have ceased.
    • Contracts providing support to national civil society organizations (CSOs) have been terminated. National implementing partners like Espace Confiance, ASAPSU, and Blety ceased all activities supported by the USAID in March.

Politically Relevant Updates

  1. Government actions:
    • The government has requested a rapid analysis of the financial gap following the cessation of US funding (internal report not yet available).
    • The Ministry of Health issued a directive on service continuity, ensuring access to ARV care and other services.
    • An antiretroviral order planning meeting has been held. ARV stocks have been secured for the next 4 months and an order schedule for the remaining part of the year has been agreed.
    • The CIPHIA (Côte d'Ivoire Population-based HIV Impact Assessment) survey has resumed, with final report availability expected by the end of September 2025.

       

  2. Civil Society Response:
    • Civil society organizations have launched an advocacy campaign, including a letter to the president, press conferences, and media interviews calling for continued support and funding for HIV programmes, including sustainable financing of civil society and community-led responses
    • Temporary measures have been implemented to maintain services and staff in certain NGOs, including minimal service, part-time contracts, and salary reductions. However, these measures cannot be sustained in the absence of additional funding. CSO are working on developing funding proposals.

       

  3. UN Involvement:
    • The UN has met with civil society and is in ongoing dialogue with CSOs re the impact and mitigation measures.
    • UNAIDS has produced and shared short videos of interviews with community leaders and beneficiaries; they have garnered more than 4000 views on social networks.
    • Government officials have been informed, sensitized, and mobilized on the impact and the need for a coordinated and systematic response. This included using UNAIDS GOALS impact model on new HIV infections and HIV related deaths in absence of a comprehensive response.
    • An analytical technical note on the impact of the US funding cuts and recommendations for mitigation strategies was produced and shared with government officials.
    • The UNAIDS Rapid AIDS Financing Tool (RAFT) has been shared and promoted with various government offices, including the Directorate General of Health, Directorate of Health Economics, National AIDS Control Program, and the prime minister's office.
    • Resources have been mobilized from various sources to ensure the continuation of critical UNAIDS activities: Expertise France for technical assistance on the sustainability roadmap, reprogramming of CDC cooperation agreement activities for approximately 150,000 USD (Expertise France, BMGF, GF/GC7 grant).

Feature Story

Impact of US funding cuts on HIV programmes in Ghana

08 April 2025

Commodity stock report

The commodity stock report elaborated by the Ghana Health Services/Ministry of Health under the umbrella of the Global Fund Logistics Support Project, provides insights into the national availability of key HIV and other health commodities. The recently released information for the month of February contains the below mentioned information on the availability of antiretroviral treatment and other HIV commodities.

  • Antiretroviral treatment:
  • Tenofovir/Lamivudine/Dolutegravir (TLD 300/300/50mg): Fully available nationwide with a slight overstock - 12.85 months of stock.
  • Dolutegravir 50mg: Fully available with overstock – 18.19 months of stock.
  • Tenofovir/Lamivudine (300/300mg): Overstock - 41.62 months of stock
  • Lopinavir/Ritonavir (200/50mg): Fully available with overstock - 17.83 months of stock. Nevertheless, there is only 64% availability across regional medical stores, with stockouts in Ashanti, Bono and Bono East regions. Distribution to these regions aims to stabilize supply.
  • Dolutegravir 10mg: Adequate stock - 10.85 months of stock with 91% availability at regional medical stores and teaching hospitals. Allocation and distribution measures aim to stabilize supply.
  • Abacavir/Lamivudine (120/60mg): Critically low stock levels at 1.22 months of stock with 64% availability at regional medical stores; new shipments are pending clearance.
  • Paediatric and syrup formulations: Zidovudine/Lamivudine tablet stock is high (25.27 months of stock). Nevirapine syrup is fully available (6.38 MoS), there are lower stock levels of Zidovudine syrup (3.17 months of stock), with an incoming shipment expected.
  • HIV and syphilis diagnostics:
    • OraQuick HIV test kits: Availability improved from 91% in January to 100% in February (4.93 months of stock).
    • HIV first response & syphilis combo test kits: Consistently at 100% availability (6.45 and 9.54 months of stock respectively).
    • Rapid diagnostic tests SD bioline: Stockouts in Ashanti and Bono, with critically low in-country stocks (0.87 months of stock). A shipment of 75,240 kits is expected in April 2025.

Politically relevant updates

  • Ghana Medical Trust Fund:  The Government of Ghana has launched the Ghana Medical Trust Fund (Mahama Cares Initiative). This presidential initiative, launched in mid-March, aims to provide financial support for people with chronic diseases. The Ghana AIDS Commission (GAC) and the UNAIDS Country Office have initiated discussions  to potentially include HIV as one of the health conditions to be covered by this mechanism.  This alternative has been also included as part of the options to explore in Ghana’s Sustainability Roadmap document. UNAIDS is providing support to the GAC to amend the terms of reference for the HIV Sustainability Technical Working group to include the documentation of the impact of US funding cuts as part of the mechanisms to streamline the coordination, monitoring and mitigation of the situation.

  • Human rights steering committee meeting: On 26 March, the Ghana AIDS Commission convened the 7th Human Rights Steering Committee Meeting, chaired by the Acting Director General. The meeting included key national and international partners, including UNAIDS, to advance the human rights agenda within the HIV response. The Committee recommended strategic engagement with the PEPFAR Coordinator to get accurate programmatic and financial information on human rights-related interventions supported by the US.
  • Courtesy visit from PEPFAR team to the Ghana AIDS Commission: On 3 April, a PEPFAR team delegation led by the PEPFAR Coordinator for West Africa II Region (Ghana, Liberia, Sierra Leone, and Mali), paid a courtesy visit to the Acting Director of the Ghana AIDS Commission and his team. This was the first official meeting of the PEPFAR Team with the Ghana AIDS Commission since January. Initial discussions on the relevance of PEPFAR’s support to the HIV response in Ghana took place.
  • Bilateral Meeting UCD-Ghana and PEPFAR Coordinator for West Africa II: On 4 April, a bilateral meeting was held at the UNAIDS country office between the UNAIDS country director and the PEPFAR Coordinator for West Africa II Region (Ghana, Liberia, Sierra Leone, and Mali).  The iscussion focused on the critical need to maintain US support in Ghana to ensure programmatic sustainability, to achieve the 95-95-95 and 10-10-10 targets, and to continue the collaboration in support of the process led by the Government of Ghana to develop the HIV Sustainability Roadmap. 
  • Coordination with Civil Society Organizations and communities.

    On 3 April, UNAIDS Country Office initiated a series of bi-weekly meetings with community-led organizations to assess the impact of the US funding cuts on their work, including their focus on human rights, stigma and discrimination, and HIV prevention. The community-led organizations agreed to design a tool to map out the projects previously funded by the US Government that have stopped and to find alternatives to close the gaps and maximize efficiency in the delivery of programmes.

Feature Story

Impact of US funding cuts on the global AIDS response — Weekly update

08 April 2025

Low- and middle-income countries across the world continue to adapt to suspensions and terminations of United States support to their national AIDS responses.

In South Africa, for example, a coalition of civil society organizations published an open letter to the government expressing their concerns following the termination of many US-funded HIV projects and demanding transparency in the government’s response to the situation. The same day, Health Minister Aaron Motsoaledi expressed confidence that the country will achieve a new national target to put an additional 1.1 million people living with HIV on treatment. He also revealed that discussions are underway with BRICS countries on how to fill gaps left by cuts in PEPFAR funding

In Malawi, the Government’s 2025-26 budget has allocated 23.3 billion Malawian Kwacha (US$13.3 million) to the Ministry of Health and plans to hire 6,000 workers to mitigate the impact of the US funding cuts.

In the Philippines, the government announced that its next budget will include some  expenditures previously supported by US funding. 

Across all countries that received significant US funding for their AIDS programmes, grassroots organizations and community health workers that provide services to vulnerable and marginalized people have been deeply affected by US funding cuts. Among 70 UNAIDS Country Offices that have submitted data on the situation, 40% reported that community-led services had been stopped by the US funding cuts. By comparison, 30% reported that services by international NGOs had been stopped, and 3% reported that government services had been stopped.

CONTINUE READING

Download situation report

Documents

Slides on 2030 Recommended Targets

15 May 2025

Feature Story

Groundbreaking ruling in Spain overturns discrimination based on HIV status

04 April 2025

CESIDA—an organization that coordinates the civil society response to HIV in Spain—and the Fernando Pombo Foundation have won an important ruling that, for the first time, recognizes discrimination based on the serological status of a person living with HIV.
The significance of this case lies in the frequency in which similar situations occur to people living with HIV, who continue to face constant stigma and discrimination despite advances in HIV treatment and prevention. 

"This ruling represents a significant achievement in the protection of the rights of people living with HIV against discrimination.  It also marks progress within the framework of the Social Pact for Non-Discrimination and Equal Treatment in relation to HIV, as well as the Global Partnership for Action to Eliminate all Forms of HIV-related Stigma and Discrimination” said Julia del Amo, Director of the Division for the Control of HIV, STIs, Viral Hepatitis, and Tuberculosis at the Ministry of Health.

On 24 October 2022, the Directorate General of Traffic (DGT) informed a person living with HIV that their driving license renewal was reduced to half the usual duration (5 years instead of 10). The only apparent reason for this decision was that the person disclosed their HIV status and treatment during the medical examination, despite this having no impact on their ability to drive.

In response to the DGT's decision, the person living with HIV authorized CESIDA—an organization that coordinates the civil society response to HIV in Spain—to file an administrative appeal. This was possible due to the provision in Article 29 of Act 15/2022, which grants active standing to social entities under certain requirements.

After hearing evidence and arguments by the pro bono legal team from Gómez-Acebo & Pombo, who represented CESIDA, the Administrative Court ruled in favor of CESIDA and annulled the DGT’s decision, finding it discriminatory. This ruling is a groundbreaking decision in Spain.

"This ruling is a crucial step in defending the rights of people with HIV. There is still much to be done, but we are firmly committed to continuing the fight against the stigmatization and discrimination that people living with HIV face in our society," said Oliver Marcos, Secretary General of CESIDA.

The ruling is one of the first cases in which, under Act 15/2022, the standing of an association established to defend human rights is recognized to combat a situation of discrimination within the realm of Public Law.

"This case sets an important precedent in Spain as it is a pioneering ruling against discrimination based on serological status, as well as for the recognition of the active standing of social entities," said Miguel Ángel Ramiro, coordinator of the Legal Clinic at the University of Alcalá. "The admission of the claim by CESIDA, without the need for individual visibility of the person with HIV, represents a key advance in the legal approach to prevent discriminations that, although not always visible, are real,” added Ana Higuera, director of the Fundación Fernando Pombo.

“This ruling in Spain represents a significant step forward in the fight against HIV-related discrimination. It highlights the importance of protecting the rights of people living with HIV and ensuring they are not subjected to unfair treatment based on their HIV status” said Umunyana Rugege, Head of Human Rights at UNAIDS.

Read more

Feature Story

Impact of US funding cuts on HIV programmes in Kenya

04 April 2025

Immediate risks and disruptions

  1. Access to Kenya electronic medical records system: There are media reports indicating that aggregate health data are not accessible through the Kenya health information system (DHIS2).
  2. Commodity availability: Short-term commodity availability has improved, with HIV commodities now being available at facilities. However, human resources for health remains impacted.
  3. Service impact: Services for HIV, TB, malaria, immunization, nutrition, and family planning programmes are still affected. HIV prevention programmes have been paused or scaled down.  

Politically relevant updates

  1. Impact of US Government funding cuts: The Kenyan Government released a comprehensive report on 24 March detailing the impact of the US Government funding cuts. Key recommendations include:
    • Immediate actions:
      • Establish an emergency health contingency fund.
      • Mobilize domestic resources and reallocate the national budget.
      • Begin high-level diplomatic negotiations with the United States.
    • Medium-to-long-term actions:
      • Strengthen public-private partnerships.
      • Expand universal health coverage and implement health insurance reforms.
      • Develop local pharmaceutical manufacturing.
      • Set up a donor coordination platform with real-time monitoring and mapping.
      • Create a structured contractual and legal framework to ensure resilience.
  2. Government convening and mitigation measures: The National AIDS & STI Control Programme and the National Syndemic Diseases Control Council are planning to take an in-depth account of the situation at the county level on HIV treatment for adults and children.

Impact highlights

  1. Civil society impact: Kenyan civil societies, led by the Kenya Legal and Ethical Issues Network, have demanded clarification from the Office of Data Protection Commission on measures taken to safeguard health data and ensure compliance with relevant data protection laws.
  2. Community-led initiatives: ISHTAR, a key populations-led organization, received funding from other donors to continue with community-led monitoring work until the end of March.
  3. UN response: The UNAIDS country office, in partnership with the National AIDS & STI Control Programme and the National Syndemic Diseases Control Council is developing a proposal to mobilize resources from the China International Development Cooperation Agency for HIV and other sexually transmitted infections prevention activities.

Documented impact on services

All facilities/service points providing antiretroviral treatment are working at a reduced capacity. The UNAIDS country office has received reports from the field that HIV commodities are now available at the facilities. The country has currently adequate HIV commodities and those that were running low at health facility level were flagged on 14 March 2025 by the Cabinet Secretary Ministry of Health for distribution by the US supported procurement agency. No stockouts are foreseen in the next 3-6 months. However, human resources for health remains impacted. 

Subscribe to